Atrial fibrillation (AF) is the most prevalent sustained arrhythmia. As the most important risk factor for embolic stroke, AF is associated with a high morbidity and mortality. Despite decades of research, successful (pharmacological and interventional) 'ablation' of the arrhythmia remains challenging. AF is characterized by a diverse aetiology, including heart failure, hypertension, and valvular disease. Based on this understanding, new treatment strategies that are specifically tailored to the underlying pathophysiology of a certain 'type' of AF are being developed. --
Introduction
Atrial fibrillation (AF) is the most common sustained arrhythmia. As the most important risk factor for embolic stroke, 1 AF is associated with a high morbidity and mortality 2 and often complicates heart failure. 3 While re-entry and multiple wavelets have been demonstrated in AF, 4, 5 the mechanisms underlying the rapid foci in the pulmonary veins, which initiate AF in patients with paroxysmal AF, 6 are presently unknown.
After the onset of AF, atrial effective refractory period (AERP) progressively shortens. 7, 8 This 'electrical remodelling' contributes to the perpetuation of the arrhythmia. 7 Additionally, atrial contractile function declines ('contractile remodelling'). Rapid atrial activation after the onset of AF leads to initial intracellular Ca 2+ overload, which induces complex changes in intracellular Ca 2+ handling. While it is well established that AF-induced changes in Ca 2+ handling contribute to contractile remodelling, current research is focused on elucidating the role of altered intracellular Ca 2+ handling in cellular pro-arrhythmic mechanisms and atrial arrhythmogenesis. Moreover, recent studies suggest that alterations in Ca 2+ -mediated intracellular signalling cascades affect excitation-transcription coupling and contribute to AF pathophysiology. Here, we review and critique unique features of atrial intracellular Ca 2+ handling. We contrast changes in Ca 2+ handling due to AF with those that precede the onset of the arrhythmia in predisposing conditions (e.g. heart failure, atrial dilatation). Finally, the contribution of altered Ca 2+ handling to three aspects of AF pathophysiology is discussed: (i) Ca 2+ -mediated signalling and transcription; (ii) atrial contractile dysfunction; and (iii) arrhythmogenicity.
Normal Ca 21 handling in atrial myocytes
Activation of voltage-gated L-type Ca 2+ channels by membrane depolarization leads to the influx of a small amount of Ca 2+ into the cardiac myocyte, which activates the release of larger quantities 
Transverse tubule (TT) organization
Transverse tubules (TTs) of cardiac myocytes are sarcolemmal invaginations of the surface membrane that occur at the Z-line and have transverse and longitudinal elements. 10 While TTs are extensively present in mammalian adult ventricular myocytes, 10 In how far these genetic alterations associated with AF might alter intracellular Ca 2+ handling is an area of active investigation.
Cardiac alternans
Cardiac alternans is a beat-to-beat variation in cardiac contractility and repolarization at a constant heart rate. Alternans primarily occurs under conditions of tachycardia 32 and in the presence of structural alterations. 33 Atrial flutter is more likely to degenerate into AF when alternans is present at the isthmus and alternans has been demonstrated during AF. 35 In how far these phenomena contribute to initiation and perpetuation of AF is currently unclear.
Heart failure and atrial dilatation
Patients with heart failure frequently develop AF. 3 Progressive atrial dilatation also forms a substrate for AF. 36 While slowing of conduction and interstitial atrial fibrosis contributes to AF development in Calcium handling in AF these entities, 36 recent work has also identified alterations in atrial Ca 2+ handling. 37, 38 In a canine heart failure model and a chronic atrial dilatation model in goats, atrial action potential duration (APD) was prolonged, 37, 38 while L-type Ca 2+ current (I Ca,L ) was moderately reduced. 39 sheep, 12, 13 it is unclear at present whether TT remodelling contributes to altered Ca 2+ handling in this model.
Altered SR function and diastolic Ca 21 leak
In goats with chronic atrial dilatation, SR Ca 2+ load was decreased. 37 Phosphorylation of phospholamban (PLB), the regulatory protein of the SR Ca 2+ ATPAse (Serca2a), increases Ca 2+ affinity of Serca2a and thus the Ca 2+ pump rate. 9 In right atrial myocardium from dilated goat atria, PLB phosphorylation was reduced at a site (Ser-16) specific for protein kinase A (PKA), which is compatible with decreased Serca2a function. Hyperphosphorylation of RyR2 is thought to increase the channels' open probability and Ca 2+ sensitivity. 40 Ca 2+ /Calmodulin-dependent kinase II (CaMKII) phosphorylation of RyR2 (Ser-2815) was increased in this model, consistent with diastolic Ca 2+ 'leak' from the SR. Thus, in chronic atrial dilatation in goats, reduced SR Ca 2+ load might be due to increased loss and reduced reuptake of Ca 2+ into the SR.
In the rapid ventricular pacing-induced canine heart failure model, on the other hand, SR Ca 2+ load was increased. 38 CaMKII-mediated phosphorylation of PLB was increased (Thr-17), compatible with increased SR Ca 2+ reuptake. RyR2 protein expression and PKA phosphorylation were reduced. 38 Of note, the intra-SR Ca 2+ buffering protein calsequestrin was also reduced, 38 which is known to facilitate spontaneous Ca 2+ release from the SR. 41 Indeed, spontaneous spontaneous Ca 2+ release from the SR. Increased SR Ca 2+ load and reduced intra-SR Ca 2+ buffering led to arrhythmogenic Ca 2+ release in atrial myocytes in this model. 38 This differs from the proposed mechanism for arrhythmogenic Ca 2+ release in AF-induced atrial remodelling, which is based on hyperphosphorylated ('leaky') RyR2 (see below).
Changes in I Ca,L preceding the onset of AF in patients
In patients at high risk for the development of AF (e.g. mitral valve disease, heart failure), I Ca,L in right atrial myocytes was reduced compared with patients at low risk for AF (coronary artery disease). 42 Also, in cells from the high-risk group, the response to phosphodiesterase inhibition, which is known to modulate I Ca,L , 43 was reduced compared with cells from the low-risk group. 42 Interestingly, in another study, right atrial cells from patients with left ventricular dysfunction had shortened APs but unchanged I Ca,L .
44
L-type Ca 2+ current data from human atrial myocytes preceding the onset of postoperative AF are inconsistent. Van Wagoner et al. 45 described larger I Ca,L in right atrial myocytes from patients who developed postoperative AF compared with myocytes from patients who did not, while another study found no differences in APD and I Ca,L in right atrial myocytes from patients with or without post-operative AF. 46 Inconsistent results in human AF likely reflect heterogeneous patient populations and differences in techniques used for detection of post-operative AF. 21 handling resulting from AF After the onset of AF, the AERP progressively shortens 7 due to a concomitant shortening of APD. 8 underlie APD shortening and also render the shape of the AP more triangular (for a review of ion currents in human AF see Workman et al. 48 ). This atrial 'electrical remodelling' contributes to the perpetuation of the arrhythmia 7 and has profound effects on intracellular Ca 2+ handling. 49 
Changes in intracellular Ca

Mechanisms underlying I Ca,L reduction in AF
I Ca,L reduction is a hallmark of AF-induced electrical remodelling. 8, 45 Reduced protein expression of the pore-forming a 1C subunit, 50 -52 which is inconsistent in AF, 53 -55 and altered channel regulation have been suggested as underlying mechanisms. I Ca,L is regulated by a variety of kinases (e.g. PKA, protein kinase C, CaMKII), 33, 56 which increase the current. While PKA signal transduction is unchanged in AF, 57 increased CaMKII activity is a consistent finding. 58, 59 Interestingly, increased CaMKII activity in AF seems to be offset by an increased phosphatase (PP) activity resulting in a net reduction of I Ca,L . 54, 55 Indeed, the PP inhibitor okadaic acid increased I Ca,L to almost normal levels in human atrial myocytes from AF patients. 54 While the CaMKII inhibitor KN-93 reduced I Ca,L in control cells, it did not affect I Ca,L in AF cells, thus further supporting the hypothesis that increased CaMKII activity is offset by a higher increase in PP activity in AF myocytes. 54 The effect of the non-receptor tyrosine kinase src on I Ca,L in human atrial myocytes is controversial. Two studies found an inhibitory effect on I Ca,L in control cells, 55, 60 which was lost in AF. 55 Another study reported no effect of src kinases on I Ca,L in control cells but found an increase in src-kinase protein expression in AF tissue. 61 66 Indeed, increased RyR2 phosphorylation at the PKA (Ser-2809) and CaMKII (Ser-2815) sites was found in human AF (Figure 2) 40,59 despite an increase in phosphatases 1 (PP1) and 2A. Interestingly, increased PP1 activity seems to be locally offset by an increased activation of (PP1)-inhibitor 1 and a general increase in CaMKII activity ( Figure 2 ). However, Serca2a function in atrial myocardium is also potently regulated by another accessory protein, sarcolipin (SLN), which is atrial specific. 69 SLN but not PLB mRNA was reduced in right atrial tissue from AF patients, 70 suggesting that SNL expression and function might be regulated in AF. Also, upregulation of the NCX, which is a consistent finding in AF (see below), would further 'unload' the SR by increasing Ca 2+ extrusion. Therefore, it is at present unclear whether (1) increased RyR2 phosphorylation and open probability lead to a significant loss of although mRNA of 5-HT 4 was increased. 78 In short-term AF in pigs, infusion of a 5-HT 4 antagonist reduced initial ERP and AP shortening. 79 Thus, while apparently regulated in AF, the role of altered 5-HT 4 signalling in Ca 2+ handling in AF is unclear at present.
Due to the activation of the renin-angiotensin system (RAS) in AF patients 80 and the fact that angiontensin II (AT II) increased Ca Calcium handling in AF spark frequencies in human atrial myocytes, 81 one might speculate that AT II-induced alteration of intracellular Ca 2+ handling is arrhythmogenic. However, the recent ANTIPAF study showed that treatment with an AT II antagonist did not reduce AF burden in patients with paroxysmal AF without structural heart disease. 82 Thus, notwithstanding its important role in atrial structural remodelling and the generation of an AF substrate, these recent results suggest that activation of RAS does not underlie the development of cellular pro-arrhythmic mechanisms in patients without structural heart disease.
Pathophysiological consequences of altered Ca 21 handling
Adaptation to the high atrial rate in AF is mediated by complex changes in intracellular signalling cascades, many of which are regulated by [Ca 2+ ] i . While intracellular Ca 2+ loading in atrial myocytes transiently increases upon the onset of AF, it gradually declines again to normal levels due to the subsequent remodelling process ( Figure 4) . 75, 83 After cessation or cardioversion of AF, the Ca 2+ load will rapidly decrease due to the restoration of a normal (slower) atrial rate. 84 These conditions are equivalent to the slow stimulation rate at which Ca 2+ handling is usually studied in in vitro experiments.
Thus, most in vitro studies of Ca 2+ handling in AF reflect the consequences of adaptation to the high rate and high Ca 2+ load (remodelling). At the same time, however, Ca 2+ loading in the cells is actually low as a consequence of the low-rate.
Ca 21 -dependent signal transduction pathways and excitation -transcription coupling
Several studies demonstrated activation of the Ca 2+ -dependent proteases calpain I and calpain II in patients with AF. 85, 86 Calpain Idependent degradation of troponin T is thought to contribute to the contractile dysfunction in AF. 86 After 24 h of rapid pacing, an in vitro study in HL-1 atrial myocytes reported a significant reduction in the plasmalemmal protein expression levels of the L-type Ca 2+ channel a 1C subunit, myolysis, and nuclear condensation. This was paralleled by a 14-fold increase in calpain activity. 87 Interestingly, inhibition of calpain, but not treatment with the calcium antagonist verapamil, prevented these ultrastructural changes. 87 Elevated [Ca 2+ ] i leads to calmodulin saturation and the subsequent activation of the phosphatase calcineurin (Cn). 88 Activated Cn dephosphorylates nuclear factor of activated T cells (NFAT), allowing translocation of NFAT into the nucleus where this transcription factor induces activation of hypertrophic pathways ( Figure 5 ). Cellular hypertrophy is a consistent finding in AF. 89, 90 Increased Cn activity and nuclear translocation of NFAT-c3 and NFAT-c4 were shown in pigs with AF. 91 Interestingly, FK506, a Cn inhibitor, abolished the hypertrophic response induced by electrical pacing of atrial tissue slices. 92 It appears, however, that the calcineurin NFAT pathway is not only involved in hypertrophic responses. A recent in vitro study demonstrated a transient increase in Cn activity in canine right atrial myocytes after 8 h of rapid pacing, which returned to baseline at 24 h. 93 Cn and NFAT inhibition fully prevented I Ca,L downregulation in these cells suggesting that the Cn NFAT pathway plays a pivotal role in frequency-dependent regulation of I Ca,L in this setting. 93 Another consequence of increased [Ca 2+ ] i during AF is the activation of CaMKII, which is discussed in sections 3.3, 4.1, and 4.3.
The acute 'Ca 2+ unloading' right after the cessation of AF together with the adaptive processes developed during AF will decrease [Ca 2+ ] i overload and calmodulin saturation. This will reduce calpain activation, thereby contributing to reverse remodelling of the atria. Indeed, changes in ion currents, action potential duration, and atrial contractility were reversible within days to weeks, 94 whereas structural alterations might only reverse very slowly if at all. Nuclear Ca 2+ transients are thought to be due to diffusion of cytosolic Ca 2+ through the nuclear pores into the nucleoplasm resulting in Ca 2+ transients that follow cytosolic Ca 2+ transients in time.
However, the presence of a Ca 2+ release machinery including IP 3 -receptors, RyR2, angiotensin receptors, and b-adrenoceptors in the nuclear envelope has been shown in numerous studies. 95 Indeed, the intrinsic Ca 2+ release in the perinuclear region and from the nuclear envelope has been documented ( Figure 5 ). IP 3 -receptor activation appears to play an important role in this process. 96 It was recently shown that after 5 days of rapid atrial pacing, the cytosolic and nuclear Ca 2+ transients were reduced in rabbit atrial myocytes. 97 Whether this is caused by reduced diffusion of Ca 2+ from the cytosol or altered intrinsic Ca 2+ release is currently unknown. IP 3 receptors are upregulated in right atrial tissue of AF patients, which might increase nuclear IP 3 signalling and perinuclear Ca 2+ release. 98 Activation of nuclear CaMKII leads to phosphorylation of proteins involved in the epigenetic regulation of cardiac myocytes. CaMKIIdependent phosphorylation of histone-deacetylases (HDAC) results in their nuclear export. Pharmacological inhibition or knockout of HDAC in ventricular myocytes prevented reactivation of a hypertrophic gene program suggesting a role of HDAC export in activation of hypertrophic genes ( Figure 5) . 99 Recently, the pathophysiological relevance of this pathway was also demonstrated in the atria. In transgenic mice, constitutive activation of HDAC resulted in cardiac hypertrophy with increased left atrial dimensions and a higher inducibility of atrial arrhythmias, including AF. 100 Pharmacological inhibition of this pathway prevented the development of an AF substrate and reduced the inducibility of atrial arrhythmias. 100 This study demonstrates the importance of Ca 2+ -dependent gene regulation in atrial myocytes and also suggests a potential role for HDAC inhibition as a new therapeutic approach in AF.
Altered Ca 21 handling in AF and its implications for atrial contractile dysfunction
After AF initiation, atrial hypocontractility develops in parallel with electrical remodelling. 101 Upon cardioversion after 5 days of AF in a goat model, shortened AERPs and hypocontractility returned to baseline in a parallel time course, 101 thus emphasizing the importance of APD, which determines ERP, for atrial contractility. Additionally, atrial cell shortening also critically depends on AP morphology, specifically the plateau potential. 102 APD prolongation is one important mechanism of antiarrhythmic therapy or cardioversion of AF. 103 Interestingly, APD prolongation and alteration of AP morphology also restored atrial contractile force in AF. 102 AVE0118, a blocker of I to and the atrial-specific ultra rapid inward rectifier potassium current (I Kur ), prolonged early repolarization (APD 30 ) and increased contractility in atrial muscle bundles from patients with AF 102 and restored atrial contractility in the AF goat model in vivo. 104 The prolongation of APD 30 increases Ca 2+ entry via 'reverse' mode of the NCX, which is the underlying mechanism of AVE0118-mediated inotropy. 102 However, changes in AP shape alone cannot fully explain atrial contractile remodelling in AF.
14 Atrial tachycardia/AF-induced remodelling, 12, 49, 63 heart failure, 13 and chronic atrial dilatation 37 all lead to a significant reduction of atrial contractile force. In all of these models, except the canine heart failure model, 38 Calcium handling in AF found in the canine heart failure model suggest that atrial contractile dysfunction in this model is due to alterations in the contractile apparatus. 38 Indeed, PKA phosphorylation of myosin-binding protein-C (MyBP-C) was reduced. 38 PKA phosphorylation of MyBP-C is important for maximum force development and stretch-dependent augmentation of force generation. 105 MyBP-C phosphorylation was increased in human right atria from AF patients together with reduced myofibrillar force generation, relaxation, and Ca 2+ sensitivity (Figure 2) . 106 This is in contrast to previous human studies where MyBP-C phosphorylation was reduced 67 and myofibrillar force generation was not altered. 107 Interestingly, oxidation markers were increased in myofibrillar proteins from AF patients, suggesting that oxidative injury might contribute to atrial contractile dysfunction. 108 Thus, atrial contractile dysfunction either due to or preceding AF, except in a canine heart failure model, is caused by a combination of decreased [Ca 2+ ] i transients and altered myofibrillar function. propagates within a single myocyte. 109 Additionally, Ca 2+ -activated I TI can occur during AP repolarization and then contribute to early afterdepolarizations (EADs), which may also trigger extrasystoles. Also, the combination of short APs and the presence of a high SR Ca 2+ load has been reported to provoke NCX-mediated late phase 3 EADs. 111 While most studies on Ca 2+ -dependent arrhythmias have been carried out in ventricular myocytes and Purkinje fibres, this mechanism has also been proposed for atrial cells. 38, 59 In AF, protein expression of NCX is upregulated. 67 This means that for any given elevation of [Ca 2+ ] i , the I NCX will be larger. Thus, a propagating wave of Ca 2+ would be associated with a higher peak I NCX .
However, these cellular proarrhythmic mechanisms have so far not been shown to underlie the initiation of sustained AF in vivo. To date, all studies addressing Ca 2+ -mediated cellular proarrhythmic mechanisms in human AF used cells from the right atrial appendage. 59, 68 Although there are alterations in Ca 2+ signalling in these cells (e.g. increased frequency of Ca 2+ sparks and waves) that are compatible with the generation of cellular proarrhythmic mechanisms, 59 ,68 the right atrial appendage is less arrhythmogenic than other areas in the right and left atrium. 6, 112 Thus, to determine the importance of these potentially pro-arrhythmic mechanisms for atrial arrhythmogenesis in vivo, it will be important to determine whether the frequency of Ca 2+ sparks and waves is also increased in atrial myocytes from more arrhythmogenic regions of human atria.
Electrical membrane resistance
The efficacy of a given level of inward current to trigger an extrasystole in a single cell depends on the total membrane resistance of the cell. For example, in human AF, inward rectifying K + currents are increased. 27, 47 Under these conditions, a larger arrhythmogenic inward current is required to produce an extrasystole than under the conditions when the inward rectifying K + current is normal (smaller). Thus, DADs and EADs would be less likely in these cells, a result that is opposite to that in ventricular myocytes in heart failure. 113 This is an area of active investigation.
Conclusions
Here, we have reviewed Ca 2+ handling alterations associated with AF.
An important observation is that changes in Ca 2+ handling in atrial cells might contribute to initiation and perpetuation of AF but also develop as a result of AF. While it is clear that AF is a multifactorial disease with alterations in atrial tissue, cellular, and molecular features, Ca 2+ instability has been demonstrated to be important to the manifestation of AF. Current work seeks to further unravel the contribution of altered intracellular Ca 2+ handling to specific subtypes of AF. Further understanding of the genetic and molecular causes of the disease forms the basis for improved treatment by antiarrhythmic agents and ablation therapies but might also lead to the development of more specific preventive concepts targeted at patients at risk for AF.
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